Skip to content

← All news

Markets

Raymond James cuts Dyne Therapeutics price target on DM1 trial risk

1 source ·1 article ·Sep 8, 15:32 UTC Dyne Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com UK ·Sep 8, 15:32 UTC

Raymond James cuts Dyne Therapeutics price target on DM1 trial risk